Caputo, D.; Coppola, A.; Quagliarini, E.; Di Santo, R.; Capriotti, A.L.; Cammarata, R.; Laganà , A.; Papi, M.; Digiacomo, L.; Coppola, R.;
et al. Multiplexed Detection of Pancreatic Cancer by Combining a Nanoparticle-Enabled Blood Test and Plasma Levels of Acute-Phase Proteins. Cancers 2022, 14, 4658.
https://doi.org/10.3390/cancers14194658
AMA Style
Caputo D, Coppola A, Quagliarini E, Di Santo R, Capriotti AL, Cammarata R, Laganà A, Papi M, Digiacomo L, Coppola R,
et al. Multiplexed Detection of Pancreatic Cancer by Combining a Nanoparticle-Enabled Blood Test and Plasma Levels of Acute-Phase Proteins. Cancers. 2022; 14(19):4658.
https://doi.org/10.3390/cancers14194658
Chicago/Turabian Style
Caputo, Damiano, Alessandro Coppola, Erica Quagliarini, Riccardo Di Santo, Anna Laura Capriotti, Roberto Cammarata, Aldo Laganà , Massimiliano Papi, Luca Digiacomo, Roberto Coppola,
and et al. 2022. "Multiplexed Detection of Pancreatic Cancer by Combining a Nanoparticle-Enabled Blood Test and Plasma Levels of Acute-Phase Proteins" Cancers 14, no. 19: 4658.
https://doi.org/10.3390/cancers14194658
APA Style
Caputo, D., Coppola, A., Quagliarini, E., Di Santo, R., Capriotti, A. L., Cammarata, R., Laganà , A., Papi, M., Digiacomo, L., Coppola, R., Pozzi, D., & Caracciolo, G.
(2022). Multiplexed Detection of Pancreatic Cancer by Combining a Nanoparticle-Enabled Blood Test and Plasma Levels of Acute-Phase Proteins. Cancers, 14(19), 4658.
https://doi.org/10.3390/cancers14194658
